Fujifilm continues to expand its biologics CDMO business, ploughing further $850m into US and UK sites

Fujifilm continues to expand its biologics CDMO business, ploughing further $850m into US and UK sites

Source: 
Biopharma Reporter
snippet: 

Fujifilm Corporation has made an additional US$850m investment to enable the expansion of its BIO-CMDO sites in the UK, at Billingham, and in the US.